Penumbra (PEN) Liabilities and Shareholders Equity (2014 - 2026)

Penumbra's (PEN) quarterly Liabilities and Shareholders Equity came in at $1.9 billion in Q1 2026, up 19.15% year-on-year from $1.6 billion in Q1 2025, and up 3.94% on a QoQ basis from $1.8 billion in Q4 2025.

Penumbra (PEN) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $1.9 billion in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 19.15% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $7.1 billion, a 16.35% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 19.13% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $1.9 billion, up from $1.8 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for PEN reached as high as $1.9 billion in Q1 2026 and fell as low as $1.3 billion in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2024.
  • Across the five-year window, Liabilities and Shareholders Equity soared 54.8% in 2022 and declined 1.49% in 2024, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then grew by 13.53% to $1.6 billion in 2023, then slipped by 1.49% to $1.5 billion in 2024, then climbed by 19.13% to $1.8 billion in 2025, then grew by 3.94% to $1.9 billion in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $1.9 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.7 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Penumbra 12.48 Bn 11.87 Bn 253.41 Mn 1.90 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.90 Bn
Dec 31, 2025 1.83 Bn
Sep 30, 2025 1.74 Bn
Jun 30, 2025 1.67 Bn
Mar 31, 2025 1.59 Bn
Dec 31, 2024 1.53 Bn
Sep 30, 2024 1.48 Bn
Jun 30, 2024 1.53 Bn
Mar 31, 2024 1.58 Bn
Dec 31, 2023 1.56 Bn
Sep 30, 2023 1.47 Bn
Jun 30, 2023 1.43 Bn
Mar 31, 2023 1.40 Bn
Dec 31, 2022 1.37 Bn
Sep 30, 2022 1.32 Bn
Jun 30, 2022 1.33 Bn
Mar 31, 2022 1.30 Bn
Dec 31, 2021 1.24 Bn
Sep 30, 2021 973.24 Mn
Mar 31, 2021 840.82 Mn